MEI Pharma, Inc. (MEIP) Financial Statements
Industry: Pharmaceutical Preparations
In fiscal 2026, MEI Pharma reported revenue of $267,000, down 99.6% from $65.3M the year before. Net income was -$71.2M (a -26647.9% net margin), or -$2.06 per diluted share. Gross margin was -24835.2% and operating margin was -24935.2%. Operating activities generated -$9.1M of cash. At fiscal year end, MEI Pharma held $42.7M in total assets against $1.1M in total liabilities, including $5.7M of cash and equivalents.
Open the full interactive MEI Pharma financials → Quarterly statements, key ratios, valuation history and price charts.
MEI Pharma Key Stats
| Share Price | $1.21 |
|---|---|
| Market Cap | $41.8M |
| Revenue YoY Growth | -99.6% |
| 52-Week Range | $0.74 – $2.26 |
| Shares Outstanding | 34.6 million (basic, 2026 Q4) |
MEI Pharma Income Statement
| FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2026 | |
|---|---|---|---|---|---|---|
| Revenue | $28.9M | $25.5M | $40.7M | $48.8M | $65.3M | $267,000 |
| Cost of Goods Sold | $2.7M | $1.4M | $0 | — | $50.8M | $66.6M |
| Gross Profit | $26.2M | $24.1M | $40.7M | — | $14.5M | -$66.3M |
| Operating Income | -$24.5M | -$69.7M | -$75.5M | -$36.8M | $14.5M | -$66.6M |
| Pre-Tax Income | -$46.0M | -$50.6M | -$54.5M | -$31.8M | $17.8M | -$71.2M |
| Income Tax | $1,000 | $8,000 | $0 | $0 | $0 | $0 |
| Net Income | -$46.0M | -$50.6M | -$54.5M | -$31.8M | $17.8M | -$71.2M |
| Diluted EPS | -$10.20 | -$13.60 | -$10.00 | -$4.78 | $2.67 | -$2.06 |
MEI Pharma Quarterly Results
| 2026 Q1 | 2026 Q2 | 2026 Q3 | 2026 Q4 | |
|---|---|---|---|---|
| Revenue | $100,000 | $60,000 | $54,000 | $53,000 |
| Net Income | -$3.6M | -$30.8M | -$23.7M | -$13.0M |
| Diluted EPS | -$0.12 | -$0.82 | -$0.66 | -$0.38 |
MEI Pharma Balance Sheet
| FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2026 | |
|---|---|---|---|---|---|---|
| Cash & Equivalents | $12.3M | $8.5M | $15.7M | $16.9M | $3.7M | $5.7M |
| Current Assets | $208.6M | $164.8M | $167.1M | $107.5M | $40.8M | $6.1M |
| Total Assets | $209.7M | $174.1M | $177.8M | $120.8M | $41.4M | $42.7M |
| Current Liabilities | $23.3M | $30.3M | $24.4M | $20.3M | $8.4M | $1.1M |
| Total Liabilities | $131.5M | $132.7M | $125.4M | $96.2M | $8.4M | $1.1M |
| Shareholders' Equity | $78.2M | $41.4M | $52.4M | $24.6M | $33.0M | $41.6M |
MEI Pharma Cash Flow Statement
| FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2026 | |
|---|---|---|---|---|---|---|
| Cash From Operations | $34.3M | -$32.0M | -$48.7M | -$52.5M | -$50.5M | -$9.1M |
| Cash From Investing | -$106.3M | $24.7M | $6.9M | $53.7M | $49.1M | -$95.1M |
| Cash From Financing | $74.8M | $3.5M | $49.1M | -$40,000 | -$11.9M | $91.9M |
| Free Cash Flow | $33.4M | -$32.7M | -$49.2M | -$52.5M | — | — |
| Dividends Paid | — | — | — | — | $11.7M | — |
Figures from MEI Pharma's 10-K and 10-Q filings with the SEC, as of 2026-10-14. Fiscal years follow the company's own reporting calendar. EPS and share counts are adjusted for later stock splits. See the full MEI Pharma financials page for every line item.
MEI Pharma Company Profile
| Ticker | MEIP |
|---|---|
| Exchange | Nasdaq |
| Industry | Pharmaceutical Preparations |
| Headquarters | San Diego, California |
| Incorporated in | Delaware |
| Fiscal Year End | June 30 |
| SEC Filer Category | Non-accelerated filer, smaller reporting company |
| SEC CIK | 0001262104 |
Frequently Asked Questions
What was MEI Pharma's revenue in fiscal 2026?
MEI Pharma (MEIP) reported revenue of $267,000 for fiscal 2026.
What is MEI Pharma's annual revenue history?
MEI Pharma's annual revenue by fiscal year: 2020: $28.9M; 2021: $25.5M; 2022: $40.7M; 2023: $48.8M; 2024: $65.3M; 2026: $267,000.
What was MEI Pharma's net income in fiscal 2026?
MEI Pharma reported net income of -$71.2M for fiscal 2026.
What was MEI Pharma's earnings per share (EPS) in fiscal 2026?
MEI Pharma's diluted EPS was -$2.06 for fiscal 2026 (adjusted for any later stock splits).
What was MEI Pharma's revenue last quarter?
In its most recent reported quarter (2026 Q4), MEI Pharma reported revenue of $53,000.
How many shares of MEI Pharma are outstanding?
MEI Pharma reported a weighted average of 34.6 million basic shares outstanding in 2026 Q4.
What is MEI Pharma's market cap?
Based on its latest closing price, MEI Pharma (MEIP) has a market capitalization of about $41.8M.
When does MEI Pharma's fiscal year end?
MEI Pharma's fiscal year end, as registered with the SEC, is June 30.
Where is MEI Pharma headquartered?
MEI Pharma lists its business address in San Diego, California in its SEC filings.